EndoChoice Holdings IPO Research Information

EndoChoice Holdings IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on EndoChoice Holdings, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
EndoChoice Holdings	GI - NYSE	$15.00-$17.00	$15.00	$14.50	6.35 million	6/5/2015
Underwriter(s): J.P. Morgan, BofA Merrill Lynch
Co-Manager(s): William Blair, Stifel
Industry: Health Care
Filing(s): Filed 2015-05-05 Terms Added 2015-05-26

EndoChoice Holdings Quote & Chart - Click for current quote - GI

About EndoChoice Holdings (adapted from EndoChoice Holdings prospectus):
They are a medical device company focused exclusively on designing and commercializing a platform of innovative products for gastrointestinal, or GI, caregivers.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "GI" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.